Pricing Log in Create free account
Saturday 17 October 2026 Export INMD’s income statement to Excel — free account

InMode Ltd.

INMD Healthcare Medical Devices

InMode Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $370.5 million, down 6.16% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 31.0% and free cash flow fell 12.6%, each against the same quarter a year earlier.

14.16 0.16 −1.12%
Market cap
$824.0M
P/E
11.3×
Fwd P/E
11.8×
Dividend yield
—
F-score
4/9
Altman Z
10.45
Beneish M
−2.25
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

InMode Ltd. (INMD) Business Profile

Updated before January 2025

Company Overview

InMode Ltd. (NASDAQ: INMD) is a leading global provider of innovative medical technologies that focus on minimally invasive aesthetic and medical treatments. Founded in 2008 and headquartered in Yokneam, Israel, the company has revolutionized the medical aesthetics industry by developing cutting-edge platforms that combine radio-frequency (RF) energy with advanced technologies. InMode was co-founded by Moshe Mizrahy, who currently serves as the Chairman and CEO, and Dr. Michael Kreindel, a physicist and expert in RF technology. Under their leadership, the company has grown into a trusted name in the medical aesthetics market, with a presence in over 60 countries worldwide.

InMode’s leadership team includes experienced professionals with deep expertise in medical technology, engineering, and business development. The company’s commitment to innovation and quality has positioned it as a leader in the field of non-invasive and minimally invasive medical treatments.

Core Business Segments

InMode operates across several core business segments, offering a diverse range of products and services that cater to both aesthetic and medical needs. These segments include:

1. Aesthetic Solutions

InMode’s aesthetic solutions focus on non-invasive and minimally invasive treatments for skin rejuvenation, body contouring, and facial remodeling. Key products include:

  • BodyTite: A minimally invasive body contouring device that uses RF-assisted lipolysis to tighten skin and reduce fat.
  • FaceTite: A facial contouring device designed to tighten skin and improve facial aesthetics.
  • Morpheus8: A fractional RF microneedling device that enhances skin texture, tone, and elasticity.
  • Evoke: A hands-free facial remodeling device that targets the cheeks, chin, and jawline.

2. Women’s Health

InMode offers solutions for women’s health, addressing issues such as vaginal rejuvenation and pelvic floor health. Key products include:

  • EmpowerRF: A platform designed for women’s wellness, offering treatments for urinary incontinence, vaginal laxity, and other conditions.

3. Medical Solutions

InMode’s medical solutions cater to physicians and surgeons, providing tools for minimally invasive procedures. Key products include:

  • AccuTite: A precision RF device for small areas such as the eyelids and nasolabial folds.
  • Optimas: A comprehensive platform that combines multiple technologies for skin rejuvenation and hair removal.

Business Model

InMode’s business model is centered around the development, manufacturing, and distribution of proprietary medical devices. The company generates revenue through the sale of its devices, consumables, and after-sales services. Key aspects of its business model include:

  • Innovation-Driven Approach: InMode invests heavily in research and development to create cutting-edge technologies that address unmet needs in the medical aesthetics market.
  • Global Distribution Network: The company has an extensive network of distributors and direct sales teams that ensure its products reach customers worldwide.
  • Recurring Revenue Streams: InMode generates recurring revenue through the sale of consumables and maintenance services for its devices.

Strategic Direction

InMode is focused on expanding its product portfolio, entering new markets, and driving sustainable growth. Key strategic initiatives include:

  • Product Innovation: The company plans to launch new devices and enhance existing platforms to meet evolving customer needs.
  • Geographic Expansion: InMode aims to strengthen its presence in emerging markets, particularly in Asia and Latin America.
  • Sustainability Goals: The company is committed to reducing its environmental footprint by adopting sustainable manufacturing practices and materials.
  • Diversification: InMode is exploring opportunities to expand into adjacent markets, such as dermatology and orthopedics.

Competitive Landscape

InMode operates in a highly competitive market, facing competition from both established players and emerging startups. Key competitors include:

  • Cutera, Inc.: A provider of laser and energy-based aesthetic systems.
  • Cynosure: A leader in light-based and RF technologies for aesthetic treatments.
  • Alma Lasers: A global innovator in laser, light, and RF-based solutions.
  • Hologic, Inc.: A company that offers a range of medical devices, including aesthetic solutions.

InMode differentiates itself through its focus on RF technology, which offers superior results compared to traditional laser-based systems.

Risk Factors

InMode faces several risks that could impact its business operations and financial performance. Key risks include:

  • Market Dependence: The company relies heavily on the medical aesthetics market, which is subject to economic fluctuations and consumer spending trends.
  • Regulatory Challenges: InMode’s products must comply with stringent regulatory requirements in different countries, which can delay product launches.
  • Supply Chain Disruptions: The company’s operations could be affected by disruptions in the supply chain, particularly for critical components.
  • Competition: Intense competition in the medical aesthetics market could pressure InMode’s pricing and margins.

Recent Developments

InMode has made significant strides in product innovation and corporate strategy. Recent developments include:

  • Launch of EmpowerRF: A new platform for women’s health that has received positive feedback from healthcare providers.
  • Expansion into Emerging Markets: The company has increased its presence in Asia and Latin America, tapping into high-growth markets.
  • Strategic Partnerships: InMode has partnered with leading healthcare providers to expand its reach and enhance its service offerings.
  • COVID-19 Impact: The pandemic initially disrupted InMode’s operations, but the company has since recovered and reported strong financial performance.

Investment Considerations

Investors considering InMode should weigh the following strengths and risks:

Strengths:

  • Innovative Product Portfolio: InMode’s cutting-edge technologies set it apart from competitors.
  • Strong Financial Performance: The company has consistently reported robust revenue growth and profitability.
  • Global Presence: InMode’s extensive distribution network ensures a steady flow of revenue from diverse markets.

Risks:

  • Market Volatility: Dependence on the medical aesthetics market makes InMode vulnerable to economic downturns.
  • Regulatory Risks: Compliance with international regulations can be challenging and costly.
  • Competition: Intense competition could impact InMode’s market share and profitability.

Conclusion

InMode Ltd. is a leader in the medical aesthetics industry, offering innovative solutions that cater to both aesthetic and medical needs. With a strong focus on research and development, the company is well-positioned to capitalize on growth opportunities in emerging markets and adjacent sectors. While it faces risks such as market dependence and regulatory challenges, InMode’s robust product portfolio and global presence make it a compelling investment opportunity. The company’s strategic initiatives and commitment to sustainability further enhance its long-term growth prospects.